News

Institutional investors are Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) biggest bettors and were rewarded after last week's US$47m market cap gain
Given the large stake in the stock by institutions, Aquestive Therapeutics' stock price might be vulnerable to their trading decisions 44% of the business is held by the top 25 shareholders Using data ...
After losing 21% in the past year, Fortescue Ltd (ASX:FMG) institutional owners must be relieved by the recent gain
Key Insights Given the large stake in the stock by institutions, Fortescue's stock price might be vulnerable to ...
Nifty momentum dull, don't expect vertical rise: Anand James on how to trade this week
Nifty is consolidating after gains. Anand James of Geojit Investments discusses key levels. Upswing attempts may face ...
What Are 5 Great Growth Stocks to Buy That Are Down 20% or More?
AMD and GitLab are two beaten-down tech stocks seeing strong AI-related growth. e.l.f. Beauty's acquisition of Rhode ...
Insider Stock Buying Reaches US$1.73m On Church & Dwight
In the last year, multiple insiders have substantially increased their holdings of Church & Dwight Co., Inc. ( ...
Index Outlook: Nifty 50, Sensex likely to bounce back from their support
Indian benchmark indices show shallow fall, positive sentiment, and potential for bullish uptrend with FPIs buying equities.
It’s time for a United States of Europe
Europe faces existential threats. The only way to secure the continent’s future is for its individual countries to band ...
InvestorsHub on MSN11h
As S&P 500 and Nasdaq Reach New Highs, What’s Next for Markets in the Second Half of 2025?
The U.S. stock market is entering the second half of 2025 with significant momentum. After a volatile start to the year, ...
Legend Biotech Corp. ADR
Legend Biotech Corp. ADR company and executive profile by Barron's. View the latest LEGN company infomation and executive bios.